Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna posted a narrower per-share loss and higher revenue in its latest quarter, but shares were tumbling anyway. Moderna posted a loss of $1. 97 a share, narrower than the loss of $2. 01 Wall Street had anticipated, and slimmer than the per-share loss of $2. 13 reported last year.

The drugmaker reiterated its full-year guidance of 10% revenue growth, evenly split between U. S. and international sales.